Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study

A blood-based biomarker to complement the clinical and neuropsychological assessments used to evaluate the risk of individuals with mild cognitive impairment (MCI) developing Alzheimer’s disease (AD) would be invaluable. Previous pilot studies by our group identified elevated platelet membrane β-sec...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuinness, Bernadette, Fuchs, Marc, Barrett, Suzanne L., Passmore, A. Peter, Johnston, Janet A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927817/
https://www.ncbi.nlm.nih.gov/pubmed/26639974
http://dx.doi.org/10.3233/JAD-150795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927817/
https://www.ncbi.nlm.nih.gov/pubmed/26639974
http://dx.doi.org/10.3233/JAD-150795

Ejemplares similares